Xiaoping He, MD, PhD

Dr. Xiaoping He is a post-doctoral research fellow in the Department of Experimental Pathology, Mayo Clinic College of Medicine. She received her M.D from Medical College of Nanjing University, Nanjing, China and her Ph.D from Second Military Medical University, Shanghai, China. Dr. He’s is intersted in early detection, cancer stem cells and understanding the molecular aspects of chemoresistant disease as it relates to ovarian cancer. Her current project under the mentorship of Dr. Shridhar is focused on defining the role of HtrA1, a serine protease that confers sensitivity to cisplatin and taxol mediated cytotoxicity, in modulating the expression level of XIAP, a protein that is over expressed and associated with chemoresistance in ovarian cancer.